Filed 12mo ago· Jun 9, 2025
25 days to disclose
Robert P. Bresnahan Jr.
RHousePennsylvania-08
↑bought
AbbVie
ABBV
$1K-$15K
+4.1% vs S&P 500
Trade dateMay 15, 2025
⚑ Pharmaceutical
Recent filings
Every politician trade, as it’s filed.
Stock trades that members of the U.S. House and Senate disclose, by law, after they buy or sell. Pulled straight from the official government websites — typically posted within hours of being filed.
Showing 1–22 of 22
Filed 12mo ago· Jun 9, 2025
25 days to discloseRobert P. Bresnahan Jr.
RHousePennsylvania-08
↑bought
Biogen
BIIB
$1K-$15K
+40.3% vs S&P 500
Trade dateMay 15, 2025
⚑ Pharmaceutical
Filed 12mo ago· Jun 9, 2025
25 days to discloseRobert P. Bresnahan Jr.
RHousePennsylvania-08
↑bought
Regeneron Pharmaceuticals
REGN
$1K-$15K
+9.4% vs S&P 500
Trade dateMay 15, 2025
Common Stock
⚑ Pharmaceutical
Filed 1.0y ago· May 31, 2025
16 days to discloseRobert P. Bresnahan Jr.
RHousePennsylvania-08
↑bought
Zoetis
ZTS
$1K-$15K
−66.2% vs S&P 500
Trade dateMay 15, 2025
⚑ Pharmaceutical
Filed 1.0y ago· May 31, 2025
16 days to discloseRobert P. Bresnahan Jr.
RHousePennsylvania-08
↓sold
Merck
MRK
$15K-$50K
+13.8% vs S&P 500
Trade dateMay 15, 2025
Stock
⚑ Pharmaceutical
Filed 1.0y ago· May 31, 2025
16 days to discloseRobert P. Bresnahan Jr.
RHousePennsylvania-08
↓sold
Incyte
INCY
$1K-$15K
+13.8% vs S&P 500
Trade dateMay 15, 2025
⚑ Pharmaceutical
Filed 1.1y ago· May 8, 2025
30 days to discloseRobert P. Bresnahan Jr.
RHousePennsylvania-08
↓sold
Moderna
MRNA
$1K-$15K
+11.7% vs S&P 500
Trade dateApr 8, 2025
⚑ Pharmaceutical
Filed 1.1y ago· May 8, 2025
30 days to discloseRobert P. Bresnahan Jr.
RHousePennsylvania-08
↓sold
Amgen
AMGN
$1K-$15K
+11.7% vs S&P 500
Trade dateApr 8, 2025
⚑ Pharmaceutical
Filed 1.1y ago· May 8, 2025
30 days to discloseRobert P. Bresnahan Jr.
RHousePennsylvania-08
↑bought
Merck
MRK
$15K-$50K
+32.2% vs S&P 500
Trade dateApr 8, 2025
Stock
⚑ Pharmaceutical
Filed 1.1y ago· May 8, 2025
30 days to discloseRobert P. Bresnahan Jr.
RHousePennsylvania-08
↓sold
Biogen
BIIB
$1K-$15K
+11.7% vs S&P 500
Trade dateApr 8, 2025
⚑ Pharmaceutical
Filed 1.1y ago· May 8, 2025
30 days to discloseRobert P. Bresnahan Jr.
RHousePennsylvania-08
↓sold
Regeneron Pharmaceuticals
REGN
$1K-$15K
+11.7% vs S&P 500
Trade dateApr 8, 2025
Common Stock
⚑ Pharmaceutical
Filed 1.1y ago· May 8, 2025
30 days to discloseRobert P. Bresnahan Jr.
RHousePennsylvania-08
↓sold
AbbVie
ABBV
$1K-$15K
+11.7% vs S&P 500
Trade dateApr 8, 2025
⚑ Pharmaceutical
Filed 1.1y ago· Apr 28, 2025
20 days to discloseRobert P. Bresnahan Jr.
RHousePennsylvania-08
↓sold
Eli Lilly
LLY
$1K-$15K
+11.7% vs S&P 500
Trade dateApr 8, 2025
⚑ Pharmaceutical
Filed 1.1y ago· Apr 28, 2025
20 days to discloseRobert P. Bresnahan Jr.
RHousePennsylvania-08
↓sold
Zoetis
ZTS
$1K-$15K
+11.7% vs S&P 500
Trade dateApr 8, 2025
⚑ Pharmaceutical
Filed 1.1y ago· Apr 28, 2025
20 days to discloseRobert P. Bresnahan Jr.
RHousePennsylvania-08
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+11.7% vs S&P 500
Trade dateApr 8, 2025
⚑ Pharmaceutical
Filed 1.1y ago· Apr 28, 2025
20 days to discloseRobert P. Bresnahan Jr.
RHousePennsylvania-08
↓sold
Pfizer
PFE
$1K-$15K
+11.7% vs S&P 500
Trade dateApr 8, 2025
Pfizer, Inc.
⚑ Pharmaceutical
Filed 1.2y ago· Mar 27, 2025
30 days to discloseRobert P. Bresnahan Jr.
RHousePennsylvania-08
↑bought
Moderna
MRNA
$1K-$15K
+46.9% vs S&P 500
Trade dateFeb 25, 2025
⚑ Pharmaceutical
Filed 1.2y ago· Mar 27, 2025
30 days to discloseRobert P. Bresnahan Jr.
RHousePennsylvania-08
↓sold
Regeneron Pharmaceuticals
REGN
$1K-$15K
Trade dateFeb 25, 2025
Common Stock
⚑ Pharmaceutical
Filed 1.2y ago· Mar 27, 2025
30 days to discloseRobert P. Bresnahan Jr.
RHousePennsylvania-08
↓sold
Merck
MRK
$15K-$50K
Trade dateFeb 25, 2025
Stock
⚑ Pharmaceutical
Filed 1.2y ago· Mar 27, 2025
30 days to discloseRobert P. Bresnahan Jr.
RHousePennsylvania-08
↓sold
Zoetis
ZTS
$1K-$15K
Trade dateFeb 25, 2025
⚑ Pharmaceutical
Filed 1.2y ago· Mar 27, 2025
30 days to discloseRobert P. Bresnahan Jr.
RHousePennsylvania-08
↑bought
Biogen
BIIB
$1K-$15K
+33.2% vs S&P 500
Trade dateFeb 25, 2025
⚑ Pharmaceutical
Filed 1.2y ago· Mar 27, 2025
30 days to discloseRobert P. Bresnahan Jr.
RHousePennsylvania-08
↑bought
AbbVie
ABBV
$1K-$15K
+5.2% vs S&P 500
Trade dateFeb 25, 2025
⚑ Pharmaceutical
| Filed | Politician | Type | Stock | Trade date | Smart move? | Size |
|---|---|---|---|---|---|---|
Jun 9, 2025 12mo ago | Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↑bought | AbbVie ABBV ⚑ Pharmaceutical · Conservation, Research, and Biotechnology | May 15, 2025 25 days to disclose | Good buy·+$1.4K+18.0% +4.1% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 9, 2025 12mo ago | Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↑bought | Biogen BIIB ⚑ Pharmaceutical · Conservation, Research, and Biotechnology | May 15, 2025 25 days to disclose | Good buy·+$4.3K+54.1% +40.3% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 9, 2025 12mo ago | Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↑bought | Regeneron Pharmaceuticals REGN Common Stock ⚑ Pharmaceutical · Conservation, Research, and Biotechnology | May 15, 2025 25 days to disclose | Good buy·+$1.9K+23.3% +9.4% vs S&P 500 | $1K-$15K midpoint $8K |
May 31, 2025 1.0y ago | Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↑bought | Zoetis ZTS ⚑ Pharmaceutical · Conservation, Research, and Biotechnology | May 15, 2025 16 days to disclose | Bad buy·−$4.2K-52.4% −66.2% vs S&P 500 | $1K-$15K midpoint $8K |
May 31, 2025 1.0y ago | Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | Merck MRK Stock ⚑ Pharmaceutical · Conservation, Research, and Biotechnology | May 15, 2025 16 days to disclose | Flat·+0.0% +13.8% vs S&P 500 | $15K-$50K midpoint $32.5K |
May 31, 2025 1.0y ago | Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | Incyte INCY ⚑ Pharmaceutical · Conservation, Research, and Biotechnology | May 15, 2025 16 days to disclose | Flat·+0.0% +13.8% vs S&P 500 | $1K-$15K midpoint $8K |
May 8, 2025 1.1y ago | Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | Moderna MRNA ⚑ Pharmaceutical · Conservation, Research, and Biotechnology | Apr 8, 2025 30 days to disclose | Flat·+0.0% +11.7% vs S&P 500 | $1K-$15K midpoint $8K |
May 8, 2025 1.1y ago | Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | Amgen AMGN ⚑ Pharmaceutical · Conservation, Research, and Biotechnology | Apr 8, 2025 30 days to disclose | Flat·+0.0% +11.7% vs S&P 500 | $1K-$15K midpoint $8K |
May 8, 2025 1.1y ago | Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↑bought | Merck MRK Stock ⚑ Pharmaceutical · Conservation, Research, and Biotechnology | Apr 8, 2025 30 days to disclose | Good buy·+$14.2K+43.8% +32.2% vs S&P 500 | $15K-$50K midpoint $32.5K |
May 8, 2025 1.1y ago | Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | Biogen BIIB ⚑ Pharmaceutical · Conservation, Research, and Biotechnology | Apr 8, 2025 30 days to disclose | Flat·+0.0% +11.7% vs S&P 500 | $1K-$15K midpoint $8K |
May 8, 2025 1.1y ago | Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | Regeneron Pharmaceuticals REGN Common Stock ⚑ Pharmaceutical · Conservation, Research, and Biotechnology | Apr 8, 2025 30 days to disclose | Flat·+0.0% +11.7% vs S&P 500 | $1K-$15K midpoint $8K |
May 8, 2025 1.1y ago | Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | AbbVie ABBV ⚑ Pharmaceutical · Conservation, Research, and Biotechnology | Apr 8, 2025 30 days to disclose | Flat·+0.0% +11.7% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 28, 2025 1.1y ago | Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | Eli Lilly LLY ⚑ Pharmaceutical · Conservation, Research, and Biotechnology | Apr 8, 2025 20 days to disclose | Flat·+0.0% +11.7% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 28, 2025 1.1y ago | Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | Zoetis ZTS ⚑ Pharmaceutical · Conservation, Research, and Biotechnology | Apr 8, 2025 20 days to disclose | Flat·+0.0% +11.7% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 28, 2025 1.1y ago | Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Conservation, Research, and Biotechnology | Apr 8, 2025 20 days to disclose | Flat·+0.0% +11.7% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 28, 2025 1.1y ago | Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | Pfizer PFE Pfizer, Inc. ⚑ Pharmaceutical · Conservation, Research, and Biotechnology | Apr 8, 2025 20 days to disclose | Flat·+0.0% +11.7% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 27, 2025 1.2y ago | Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↑bought | Moderna MRNA ⚑ Pharmaceutical · Conservation, Research, and Biotechnology | Feb 25, 2025 30 days to disclose | Good buy·+$3.7K+46.6% +46.9% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 27, 2025 1.2y ago | Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | Regeneron Pharmaceuticals REGN Common Stock ⚑ Pharmaceutical · Conservation, Research, and Biotechnology | Feb 25, 2025 30 days to disclose | Flat·+0.0% | $1K-$15K midpoint $8K |
Mar 27, 2025 1.2y ago | Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | Merck MRK Stock ⚑ Pharmaceutical · Conservation, Research, and Biotechnology | Feb 25, 2025 30 days to disclose | Flat·+0.0% | $15K-$50K midpoint $32.5K |
Mar 27, 2025 1.2y ago | Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | Zoetis ZTS ⚑ Pharmaceutical · Conservation, Research, and Biotechnology | Feb 25, 2025 30 days to disclose | Flat·+0.0% | $1K-$15K midpoint $8K |
Mar 27, 2025 1.2y ago | Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↑bought | Biogen BIIB ⚑ Pharmaceutical · Conservation, Research, and Biotechnology | Feb 25, 2025 30 days to disclose | Good buy·+$2.6K+32.9% +33.2% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 27, 2025 1.2y ago | Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↑bought | AbbVie ABBV ⚑ Pharmaceutical · Conservation, Research, and Biotechnology | Feb 25, 2025 30 days to disclose | Good buy·+$399+5.0% +5.2% vs S&P 500 | $1K-$15K midpoint $8K |